Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and chemotherapy (mFOLFOX6) in 1L HER2-negative, metastatic gastric cancer patients, ...
Discover Alabama's 2026 football commits and stay informed about recruitment updates and player commitments for the upcoming season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback